Can We Override Clopidogrel Resistance?
- 2 June 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 119 (21) , 2854-2857
- https://doi.org/10.1161/circulationaha.108.857722
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care AssayCirculation, 2009
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyThe Lancet, 2009
- Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance DoseCirculation, 2008
- Drug-Eluting Stent and Coronary ThrombosisCirculation, 2007
- Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery DiseaseCirculation, 2007
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006